By using single-cell RNA sequencing (scRNA-seq) of CD45-positive (CD45+) immune cells isolated from early- and late-stage tumors, we sought to delineate the functional profiles of various subsets of immune cells and identify fundamental immunological dynamics during tumor progression. This evidence concerns the gene PTPRC and neoplasm.